Found 135 matching trials
Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer
PHASE2The goal of this clinical trial is to learn whether new adjuvant radiothera...
Location
Multiple Locations
Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage
PHASE3Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy...
Location
Sun Yat-sen University Cancer Center
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
PHASE2Aim of the trial is to evaluate the activity and tolerability of the anti P...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Liver Cell Transplant for Phenylketonuria
PHASE1Human phenylketonuria (PKU) results from phenylalanine hydroxylase (PAH) de...
Location
UPMC Children's Hospital of Pittsburgh
Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma
PHASE3This is a randomized, prospective, multicenter study....
Location
Sichuan Cancer Hospital & Institute
Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal Carcinoma
N/ARadiation therapy has become the preferred treatment for nasopharyngeal can...
Location
Jiangsu Cancer Hospital
Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)
NAIntervention prospective monocentric one arm study on the use of neoadjuvan...
Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma
PHASE2The purpose of this study is to evaluate the efficacy and tolerability of r...
Location
Fudan University Cancer Hospital
Hepatocyte Transplantation for Liver Based Metabolic Disorders
PHASE1The purpose of this research study is to determine whether partial irradiat...
Location
Children's Hospital of Pittsburgh of UPMC
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer
PHASE2This study aims to assess the efficacy of durvalumab in combination with ra...
Location
Centre Oscar Lambret, CLCC UNICANCER